All In Biotech

Drug Trial Radar · NCT07631637

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

360

Planned (sponsor's estimate)

Start

Jul 6, 2026

Primary completion

Jan 29, 2029

Study completion Jan 29, 2029

Sponsor

Lead sponsor
Regeneron PharmaceuticalsRegeneron (REGN)
Sponsor type
Industry
First posted
Jun 8, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will test a Regeneron study drug called ALN-CIDEB to find out whether it may help treat a liver disease called MASH. In this study, researchers are looking at the effect of ALN-CIDEB on reducing liver fat, liver injury, and liver scarring. The study will compare ALN-CIDEB with placebo to understand how well ALN-CIDEB works to lower the amount of fat in the liver. The study is looking at: * What side effects ALN-CIDEB might cause * How well ALN-CIDEB works to change liver fat, liver injury, and liver scarring * How the body and the liver change after having ALN-CIDEB, which can help researchers understand why ALN-CIDEB works better for some people than others

Conditions

  • Metabolic Dysfunction-Associated Steatohepatitis
  • MASH

Interventions

  • ALN-CIDEBDrug

    Administered per the protocol

  • PlaceboDrug

    Administered per the protocol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change from Baseline in Liver Fat by Magnetic Resonance Imaging-derived Proton Density Fat Fraction (MRI-PDFF)Time frame: At week 52

Locations

24 sites in 3 countries. Site status is shown where the registry gives one.

  • Adobe Clinical Research

    Tucson, Arizona · Recruiting

  • The Institute for Liver Health II LLC dba Arizona Liver Health

    Tucson, Arizona · Recruiting

  • Del Sol Research Management, LLC

    Tucson, Arizona · Recruiting

  • California Liver Research Institute

    Pasadena, California · Recruiting

  • Inland Empire Clinical Trials

    Rialto, California · Recruiting

  • Universal Axon Clinical Research

    Doral, Florida · Recruiting

  • Southwest General Healthcare Center

    Fort Myers, Florida · Recruiting

  • Genoma Research Group, Inc.

    Miami, Florida · Recruiting

  • Med Research of Florida, LLC

    Miami, Florida · Recruiting

  • Indiana University School of Medicine

    Indianapolis, Indiana · Recruiting

  • Kansas Medical Clinic

    Topeka, Kansas · Recruiting

  • Tandem Clinical Research

    Marrero, Louisiana · Recruiting

  • Tandem Clinical Research

    Metairie, Louisiana · Recruiting

  • Geisinger Medical Center

    Danville, Pennsylvania · Recruiting

  • Quality Medical Research - Nashville

    Nashville, Tennessee · Recruiting

  • Texas Clinical Research Institute, LLC

    Arlington, Texas · Recruiting

  • American Research Corporation

    Austin, Texas · Recruiting

  • Methodist Dallas Medical Center

    Dallas, Texas · Recruiting

  • Advanced Medical Trials

    Georgetown, Texas · Recruiting

  • Pioneer Research Solutions, Inc.

    Houston, Texas · Recruiting

  • American Research Corporation at The Texas Liver Institute

    San Antonio, Texas · Recruiting

  • Siena Research Network

    Sugar Land, Texas · Recruiting

  • Fundacion de Investigacion (FDI) Clinical Research

    San Juan, Puerto Rico · Recruiting

  • The Newcastle upon Tyne Hospitals NHS Trust

    Newcastle upon Tyne, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.